KANG [iKang Healthcare] SC 13D/A: Execution Version AMENDED AND RESTATED THIS Agreement Chairman

[Execution Version AMENDED AND RESTATED THIS Agreement Chairman TIFL SMI Chairman Holding Companies Chairman Parties FountainVest 天津君联赟鹏企业管理咨询合伙企业（有限合伙） Sponsors Party Parties WHEREAS, Original Consortium Agreement Transaction Target Exchange Act Holdco WHEREAS, (a) in connection with the Transaction, the Parties propose to form a new company (“ WHEREAS, Schedule A Proposal Target Board WHEREAS, in accordance with the terms of this Agreement,] []

By | 2016-03-22T14:47:32+00:00 January 5th, 2016|Categories: Chinese Stocks, KANG, Webplus ver|Tags: , , , , , |0 Comments
Read More

QUNR [Qunar Cayman Islands] 6-K: Qunar Announces Management and Board Changes BEIJING, Jan.

[Qunar Announces Management and Board Changes BEIJING, Jan. 4, 2016 (GLOBE NEWSWIRE) — Qunar Cayman Islands Limited (NASDAQ: QUNR) (“Qunar” or the “Company”), China’s leading mobile and online travel platform, today announced changes to its management and board of directors (the “Board”), which are effective as of January 4, 2016. Mr. Zhenyu Chen, Qunar’s Executive Vice President and Head of] [QUNAR CAYMAN ISLANDS LIMITED Xiaolu Zhu]

By | 2016-03-21T14:43:48+00:00 January 5th, 2016|Categories: Chinese Stocks, QUNR, Webplus ver|Tags: , , , , , |0 Comments
Read More

TAOM [Taomee] SC 13E3: Use these links to rapidly review the document

[Use these links to rapidly review the document PRELIMINARY PROXY STATEMENT OF THE COMPANY Shareholders of Taomee Holdings Limited You are cordially invited to attend an extraordinary general meeting of shareholders of Taomee Holdings Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), to be held on At the extraordinary general meeting,] [Execution Version EQUITY COMMITMENT LETTER December 11, 2015 Orient TM Parent Limited 36/F, Building No. 2, Orient International Financial Plaza 318 South Zhongshan Road Shanghai 200010 People’s Republic of China Ladies and Gentlemen: Merger Agreement Company Parent Merger Sub Equity Commitment Letter We refer to the Agreement and Plan of Merger dated as of the date hereof (as may be] [Taomee Holdings Limited Fairness Analysis Presented to the Special Committee of Independent Directors December 11, 2015 The information contained herein is of a confidential nature and is intended for the use of the persons or firm to whom it is furnished by us. Reproduction, publication, or dissemination of portions hereof may not be made without prior approval of Duff &] [SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT TAOMEE HOLDINGS LIMITED (Name of the Issuer) Taomee Holdings Limited (Names of Persons Filing Statement) Ordinary shares, par value US$0.00002 per share (Title of Class of Securities) 1 87600Y106 (CUSIP Number) Sam Lawn, Chief Financial Officer Mr. Benson Haibing Wang Orient TM Parent Limited Dongzhengruibo (Shanghai) Investment Center (Name, Address and Telephone Number of]

By | 2016-04-01T09:07:17+00:00 January 5th, 2016|Categories: Chinese Stocks, TAOM, Webplus ver|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate

[Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate BEIJING, December 10, 2015 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company has obtained approval to begin human clinical trials on its Sabin Inactivated Polio Vaccine (or “sIPV”) candidate. In preparation of beginning human clinical trials, Sinovac is currently finalizing the clinical] [Sinovac Obtains New Drug Certificate and Production License for EV71 Vaccine BEIJING, January 4, 2016--Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the China Food and Drug Administration (CFDA) issued the new drug certificate and production license for its Enterovirus 71 ("EV71") vaccine. As previously announced, the CFDA completed its Good Manufacturing Practices] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. 6-K 1 v428191_6k.htm FORM 6-K]

By | 2016-03-16T06:07:43+00:00 January 5th, 2016|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

TEDU [Tarena International] SC 13G/A: SCHEDULE 13G (Amendment No. 1)* TARENA INTERNATIONAL, INC.

[SCHEDULE 13G (Amendment No. 1)* TARENA INTERNATIONAL, INC. (Name of Issuer) Class A ordinary shares, par value US$0.001 per share (Title of Class of Securities) 876108101 1 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of this Statement) [ X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover]

By | 2016-03-16T09:49:34+00:00 January 5th, 2016|Categories: Chinese Stocks, TEDU, Webplus ver|Tags: , , , , , |0 Comments
Read More

GIGM [GIGAMEDIA] 6-K: For further information contact: Amanda Chang GigaMedia Regains

[For further information contact: Amanda Chang GigaMedia Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule TAIPEI, Taiwan, January 04, 2016 – GigaMedia Limited (NASDAQ: GIGM), an online games and computing services provider, today announced that on December 31, 2015, NASDAQ notified the Company that it has regained compliance with Rule 5550(a)(2), which requires a minimum bid price of $1.00] [FORM 6-K January 4, 2015 GIGAMEDIA LIMITED ——————————————————————————————————— 8F, NO. 22, LANE 407,SEC. 2, TIDING BLVD.,TAIPEI 114, TAIWAN ——————————————————————————————————— x x n/a GIGAMEDIA LIMITED Collin Hwang Collin Hwang Chief Executive Officer Description 99.1 Regaining Compliance with Nasdaq 6-K 1 htm_9938.htm LIVE FILING]

By | 2016-03-31T13:41:20+00:00 January 4th, 2016|Categories: Chinese Stocks, GIGM, Webplus ver|Tags: , , , , , |0 Comments
Read More

CSIQ [Canadian Solar] 6-K: QuickLinks — Click here to rapidly navigate through

[QuickLinks -- Click here to rapidly navigate through this document CANADIAN SOLAR INC. Common Shares January 4, 2016 CREDIT SUISSE SECURITIES (USA) LLC Dear Sirs: 1. Introductory . Canadian Solar Inc., a corporation incorporated under the laws of Canada (" Company "), agrees with Credit Suisse Securities (USA) LLC (the " Manager ") to issue and sell from time to] [QuickLinks -- Click here to rapidly navigate through this document Barristers & Solicitors January 4, 2016 Canadian Solar Inc. Dear Sirs and Mesdames: Re: Form F-3 The facts, as we understand them, and upon which with your permission we rely in rendering the opinion herein, are set forth in the Registration Statement. In addition, in our capacity as counsel, we] [QuickLinks -- Click here to rapidly navigate through this document January 4, 2016 Canadian Solar Inc. Re: Canadian Solar Inc. Ladies and Gentlemen: We have acted as special United States tax counsel to Canadian Solar Inc., a Canadian company (the " Company "), in connection with the in connection with the offering (the " Offering ") of up to US$] [QuickLinks -- Click here to rapidly navigate through this document January 4, 2016 Canadian Solar Inc. Ladies and Gentlemen: We have acted as special People's Republic of China (" PRC ") legal counsel to Canadian Solar Inc. (the " Company ") in connection with the offering (the " Offering" ) of up to US$ 100,000,000 common shares of the Company] [FORM 6-K CANADIAN SOLAR INC. 545 Speedvale Avenue West ý Form 20-F o Form 40-F o o CANADIAN SOLAR INC. Form 6-K TABLE OF CONTENTS Incorporation by Reference 3]

By | 2016-04-03T11:19:23+00:00 January 4th, 2016|Categories: Chinese Stocks, CSIQ, Webplus ver|Tags: , , , , , |0 Comments
Read More

CSIQ [Canadian Solar] 424B5: PROSPECTUS SUPPLEMENT (To Prospectus dated January 4, 2016)

[PROSPECTUS SUPPLEMENT (To Prospectus dated January 4, 2016) $100,000,000 Common Shares Canadian Solar Inc. We have entered into a distribution agency agreement with Credit Suisse Securities (USA) LLC, which we refer to as Credit Suisse or the sales agent, relating to our common shares, with no par value, offered by this prospectus supplement and the accompanying prospectus. In accordance with]

By | 2016-04-03T11:24:22+00:00 January 4th, 2016|Categories: Chinese Stocks, CSIQ, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar